Skip to main content
2023 IKCS: North America Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Video

Track: CME Session

SESSION 11: Cellular Therapies - Novel Immunotherapeutics

Saturday, November 11, 2023
9:25 AM – 10:15 AM CST

    Speaker(s)

  • Sally Dale

    Self
    Indianola, IA, United States

    Disclosure(s): No financial relationships to disclose

  • Mike Hurwitz, MD, PhD

    Yale Cancer Center
    Yale School of Medicine
    New Haven, Connecticut, United States

    Disclosure(s): Contract Research: achilles therapeutics (Ongoing); CRISPR Therapeutics (Ongoing); Iovance (Ongoing)
    Non-CE Consulting: affini-T (Terminated, June 3, 2023); CRISPR Therapeutics (Terminated, June 3, 2023); Exelixis (Terminated, June 3, 2023); Janssen (Terminated, June 3, 2023); Pliant Therapeutics (Terminated, June 3, 2023); Regeneron (Terminated, June 3, 2023); Tscan (Terminated, June 3, 2023)

    Slides

  • Vivek Narayan, MD, MSCE

    University of Pennsylvania
    University of Pennsylvania, Pennsylvania, United States

    Disclosure(s): Non-CE Consulting: Bristol Meyers Squibb (Terminated); Exelixis (Terminated); Janssen (Terminated); Merck (Terminated); Pfizer (Terminated); Regeneron (Terminated)

    Slides

  • Phillip Pierorazio, MD

    Penn Medicine
    Penn Presbyterian Medical Center, Penn Medicine
    Philadelphia, Pennsylvania, United States

    Disclosure(s): Non-CE Consulting: Amgen, Merck, Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, SeaGen, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Genome & Company, AAA, Peloton Therapeutics, and Pfizer (Terminated)

  • Qing Zhang, PhD

    UT Southwestern
    UT Southwestern Medical Center

    Disclosure(s): Non-CE Consulting: Exelixis (Ongoing)

    Slides

Presentations:

  • 9:25 AM – 9:30 AM CST
    PATIENT PERSPECTIVE

    Speaker: Sally A. Dale – Self

  • 9:30 AM – 9:40 AM CST
    Preclinical Development of Novel Immunotherapy Targets and Cellular Therapy

    Speaker: Qing Zhang, PhD – UT Southwestern

  • 9:40 AM – 9:50 AM CST
    CAR-T Landscape

    Speaker: Mike Hurwitz, MD, PhD – Yale Cancer Center

  • 9:50 AM – 10:00 AM CST
    Novel Immunotherapy in Early Phase Clinical Development for RCC

    Speaker: Vivek Narayan, MD, MSCE – University of Pennsylvania

  • 10:00 AM – 10:15 AM CST
    Session 11 Q&A

    Speaker: Phillip M. Pierorazio, MD – Penn Medicine